Literature DB >> 24155637

Patterns of practice in the prescription of palliative radiotherapy for the treatment of bone metastases at the Rapid Response Radiotherapy Program between 2005 and 2012.

N Thavarajah1, L Zhang, K Wong, G Bedard, E Wong, M Tsao, C Danjoux, E Barnes, A Sahgal, K Dennis, L Holden, N Lauzon, E Chow.   

Abstract

OBJECTIVE: We examined whether patterns of practice in the prescription of palliative radiation therapy for bone metastases had changed over time in the Rapid Response Radiotherapy Program (rrrp).
METHODS: After reviewing data from August 1, 2005, to April 30, 2012, we analyzed patient demographics, diseases, organizational factors, and possible reasons for the prescription of various radiotherapy fractionation schedules. The chi-square test was used to detect differences in proportions between unordered categorical variables. Univariate logistic regression analysis and the simple Fisher exact test were also used to determine the factors most significant to choice of dose-fractionation schedule.
RESULTS: During the study period, 2549 courses of radiation therapy were prescribed. In 65% of cases, a single fraction of radiation therapy was prescribed, and in 35% of cases, multiple fractions were prescribed. A single fraction of radiation therapy was more frequently prescribed when patients were older, had a prior history of radiation, or had a prostate primary, and when the radiation oncologist had qualified before 1990.
CONCLUSIONS: For patients with bone metastasis, a single fraction of radiation therapy was prescribed with significantly greater frequency.

Entities:  

Keywords:  Palliative radiation therapy; bone metastasis; dose fractionation; patterns of practice

Year:  2013        PMID: 24155637      PMCID: PMC3805409          DOI: 10.3747/co.20.1457

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  34 in total

1.  [A randomized trial of single and multifraction radiation therapy for bone metastasis: a preliminary report].

Authors:  K Kagei; K Suzuki; H Shirato; T Nambu; H Yoshikawa; G Irie
Journal:  Gan No Rinsho       Date:  1990-12

2.  Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.

Authors:  William F Hartsell; Charles B Scott; Deborah Watkins Bruner; Charles W Scarantino; Robert A Ivker; Mack Roach; John H Suh; William F Demas; Benjamin Movsas; Ivy A Petersen; Andre A Konski; Charles S Cleeland; Nora A Janjan; Michelle DeSilvio
Journal:  J Natl Cancer Inst       Date:  2005-06-01       Impact factor: 13.506

3.  Proceedings: Cancer of the kidney--radiation therapy and its indications in non-Wilms' tumors.

Authors:  J M Vaeth
Journal:  Cancer       Date:  1973-11       Impact factor: 6.860

4.  Rapid course radiation therapy vs. more standard treatment: a randomized trial for bone metastases.

Authors:  M Niewald; H J Tkocz; U Abel; T Scheib; K Walter; C Nieder; K Schnabel; W Berberich; R Kubale; M Fuchs
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-12-01       Impact factor: 7.038

5.  An innovative rapid response radiotherapy program to reduce waiting time for palliative radiotherapy.

Authors:  C Danjoux; E Chow; A Drossos; L Holden; C Hayter; M Tsao; T Barnes; E Sinclair; M Farhadian
Journal:  Support Care Cancer       Date:  2005-04-23       Impact factor: 3.603

Review 6.  Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules.

Authors:  M N Gaze; C G Kelly; G R Kerr; A Cull; V J Cowie; A Gregor; G C Howard; A Rodger
Journal:  Radiother Oncol       Date:  1997-11       Impact factor: 6.280

7.  A prospective randomised trial of 4 Gy or 8 Gy single doses in the treatment of metastatic bone pain.

Authors:  P J Hoskin; P Price; D Easton; J Regan; D Austin; S Palmer; J R Yarnold
Journal:  Radiother Oncol       Date:  1992-02       Impact factor: 6.280

Review 8.  Palliative radiotherapy trials for bone metastases: a systematic review.

Authors:  Edward Chow; Kristin Harris; Grace Fan; May Tsao; Wai M Sze
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

9.  International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice?

Authors:  Alysa Fairchild; Elizabeth Barnes; Sunita Ghosh; Edgar Ben-Josef; Daniel Roos; William Hartsell; Tanya Holt; Jackson Wu; Nora Janjan; Edward Chow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-05-21       Impact factor: 7.038

10.  Single versus multiple fractions of palliative radiotherapy for bone metastases: a randomized clinical trial in Iranian patients.

Authors:  F Amouzegar-Hashemi; H Behrouzi; A Kazemian; B Zarpak; P Haddad
Journal:  Curr Oncol       Date:  2008-06       Impact factor: 3.677

View more
  4 in total

1.  Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis.

Authors:  Sivakumar Vijayaraghavalu; Yue Gao; Mohammed Tanjimur Rahman; Richard Rozic; Nima Sharifi; Ronald J Midura; Vinod Labhasetwar
Journal:  Biomaterials       Date:  2019-10-18       Impact factor: 12.479

Review 2.  International patterns of practice in radiotherapy for bone metastases: A review of the literature.

Authors:  Rachel McDonald; Edward Chow; Henry Lam; Leigha Rowbottom; Hany Soliman
Journal:  J Bone Oncol       Date:  2014-11-07       Impact factor: 4.072

3.  CT-Guided 125I Seed Interstitial Brachytherapy as a Salvage Treatment for Recurrent Spinal Metastases after External Beam Radiotherapy.

Authors:  Lihong Yao; Qianqian Cao; Junjie Wang; Jiwen Yang; Na Meng; Fuxin Guo; Yuliang Jiang; Suqing Tian; Haitao Sun
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

4.  Are radiation oncologists following guidelines? An audit of practice in patients with uncomplicated bone metastases.

Authors:  Vanessa Di Lalla; Bernard Fortin; Catherine Pembroke; Carolyn Freeman; Michael Yassa; Tarek Hijal
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2019-01-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.